Vimarsana
Biggest News Aggregation in the World

Page 10 - Neuronetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuronetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuronetics Inc Today - Breaking & Trending Today

GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING - Vimarsana News

GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING

/PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-first amendment (the...

GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING - Vimarsana News

GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

/PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twentieth amendment (the...

GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING - Vimarsana News

GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

TORONTO, Dec. 5, 2023 /PRNewswire/ - Greenbrook TMS Inc. today announced that it has entered into the twentieth amendment to the Company's credit facility with affiliates of Madryn Asset...

NeuroStar TMS Receives Expanded Regulatory Approval in Japan - Vimarsana News

NeuroStar TMS Receives Expanded Regulatory Approval in Japan

Technological advances reduce time and increase efficiency for MDD treatmentMALVERN, Pa., Dec. 04, 2023 -- Neuronetics, Inc. , a medical technology company focused on designing, developing, and...

Analyzing Neuronetics (NASDAQ:STIM) and Medical Imaging (OTCMKTS:MEDD) - Vimarsana News

Analyzing Neuronetics (NASDAQ:STIM) and Medical Imaging (OTCMKTS:MEDD)

Neuronetics (NASDAQ:STIM – Get Free Report) and Medical Imaging (OTCMKTS:MEDD – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Analyst Recommendations This is a summary of current ratings […]